COVID-19 Update | May 15, 2020

COVID-19 News

COVID-19 Update | May 15, 2020

May 15, 2020

The California Biotechnology Foundation is committed to keeping you up to date on COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of May 15, 2020. Notable advancements include:

  • Gilead provides five generic drug manufacturers the rights and information needed to make the company’s COVID-19 drug, remdesivir.
  • Pfizer CEO and Chairman Albert Bourla explains that the company plans to expand human trials of its experimental coronavirus vaccine to thousands of test patients by September.
  • Regeneron, Eli Lilly, Amgen and Vir Biotechnology are working to develop therapies that could give people short-term protection from the coronavirus or help treat those who are exposed or infected.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.


Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new


If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].